Phase 1 Advanced Solid Tumor Malignancies Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors
Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc255 enrolled1 locationNCT07299747
Recruiting
Phase 1Phase 2
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc310 enrolled5 locationsNCT07136779
Recruiting
Phase 1
Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors
Advanced Solid MalignanciesAdvanced Solid Tumor Malignancies
West China Hospital12 enrolled1 locationNCT06927297
Recruiting
Phase 1Phase 2
HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies
Advanced Solid Tumor Malignancies
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.100 enrolled3 locationsNCT06649708